- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: AZD6738 (ceralasertib)
Total 85 results
-
AstraZenecaActive, not recruitingAdvanced Solid TumoursUnited States, France, Spain
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic LeukemiaUnited Kingdom, Poland
-
AstraZenecaActive, not recruitingNon-Small Cell Lung CancerFrance, Spain, United States, Canada, Korea, Republic of, Austria, Israel, Germany
-
AstraZenecaCompletedHead and Neck Squamous Cell CarcinomaTaiwan, United States, France
-
University of Michigan Rogel Cancer CenterActive, not recruitingProstate CancerUnited States
-
Dana-Farber Cancer InstituteAstraZeneca; Osteosarcoma InstituteRecruitingOsteosarcoma | Osteosarcoma RecurrentUnited States
-
AstraZenecaParexelWithdrawnOvarian CancerUnited States, Italy, Canada, Spain
-
AstraZenecaActive, not recruitingAdvanced Solid MalignanciesJapan
-
Massachusetts General HospitalAstraZenecaRecruiting
-
Royal Marsden NHS Foundation TrustAstraZeneca; Cancer Research UK; RM/ICR Biomedical Research CentreActive, not recruitingSolid Tumour Refractory to Conventional TreatmentUnited Kingdom
-
IFOM ETS - The AIRC Institute of Molecular OncologyAstraZenecaRecruitingTriple Negative Breast Cancer MetastaticItaly
-
Assistance Publique Hopitaux De MarseilleRecruitingNon-small Cell Lung CancerFrance
-
University of LeedsUniversity College London Hospitals; The Leeds Teaching Hospitals NHS Trust; University... and other collaboratorsRecruitingNon Small Cell Lung CancerUnited Kingdom
-
AstraZenecaRecruitingAdv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian CancerSpain, Korea, Republic of, United States, Belgium, United Kingdom, France, Canada, Hungary, Australia
-
AstraZenecaCLL ConsortiumCompletedB Cell Lymphomas | 11q-deleted Relapsed/Refractory Chronic Lymphocytic Leukaemia (CLL), | Prolymphocytic Leukaemia (PLL)United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
AstraZenecaActive, not recruitingAdvanced or Metastatic NSCLCRussian Federation
-
AstraZenecaActive, not recruiting
-
AstraZenecaParexelCompletedCoronary Artery Disease (CAD)United Kingdom
-
AstraZenecaParexelCompletedChronic Kidney DiseaseUnited Kingdom
-
University of NottinghamCompletedInsulin Resistance | Age ProblemsUnited Kingdom
-
AstraZenecaActive, not recruitingMelanomaFrance, Germany, Italy, Spain, Belgium, Canada, Poland, Korea, Republic of, United Kingdom, United States, Australia
-
Seoul National University HospitalRecruitingBile Duct Cancer | Chemotherapy EffectKorea, Republic of
-
Se-Hoon LeeAstraZenecaCompletedSmall Cell Lung CancerKorea, Republic of
-
AstraZenecaTerminatedType 2 DiabetesSweden
-
National Cancer Institute (NCI)RecruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditionsUnited States
-
Mette M BergerTexas A&M UniversityCompletedCritical Illness | Muscle WeaknessSwitzerland
-
Rahul AggarwalAstraZenecaRecruitingClear Cell Renal Cell Carcinoma | Metastatic Renal Cell Carcinoma | Endometrial Cancer | Stage III Renal Cell Cancer | Locally Advanced Malignant Solid Neoplasm | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Metastatic Malignant Solid Neoplasm | Metastatic Urothelial Carcinoma | Stage IV... and other conditionsUnited States
-
AstraZenecaQuotient SciencesCompletedCardiovascular DiseaseUnited Kingdom
-
AstraZenecaParexelCompletedCoronary Artery DiseaseUnited Kingdom
-
Samsung Medical CenterActive, not recruitingGastric Adenocarcinoma | Malignant MelanomaKorea, Republic of
-
AstraZenecaRecruitingInflammatory DiseasesUnited Kingdom
-
AstraZenecaCompleted
-
AstraZenecaNational Institute of Mental Health (NIMH)CompletedTreatment Resistant Major Depressive DisorderUnited States
-
AstraZenecaParexelRecruitingHealthy Subjects | Crohns DiseaseUnited Kingdom
-
National University Heart Centre, SingaporeAstraZenecaRecruitingAcute Coronary SyndromeAustralia, New Zealand, Singapore
-
AstraZenecaCompletedCoronary Artery DiseaseDenmark, Finland, Sweden
-
AstraZenecaCompleted
-
AstraZenecaCompletedCardiovascular Disease | Healthy Male SubjectsUnited Kingdom
-
AstraZenecaCompletedMajor Depressive DisorderUnited Kingdom
-
Samsung Medical CenterCompleted
-
University of PennsylvaniaAstraZeneca; Myriad Genetics, Inc.RecruitingHigh Grade Serous CarcinomaUnited States
-
AstraZenecaRecruitingCOVID-19 | SARS-CoV-2 InfectionUnited States
-
AstraZenecaRecruiting
-
AstraZenecaWithdrawn
-
AstraZenecaParexelRecruitingAdvanced or Metastatic Non-Small Cell Lung CancerChina, Netherlands, Korea, Republic of, Italy, Spain, Canada, Hungary, Japan, Argentina, France, United States, Taiwan, Poland, Serbia, United Kingdom, Hong Kong, Brazil, Germany, Belgium, Romania, India, Ireland, Australia
-
Institute of Cancer Research, United KingdomAstraZenecaRecruitingBreast NeoplasmUnited Kingdom
-
Samsung Medical CenterCompletedRefractory CancerKorea, Republic of